[ FUNDER ENTITY RECORD ]
GlaxoSmithKline
VERIFIED SOURCE
ID: 001276 · glaxosmithkline
M SOURCE NODE — CAPITAL PROVIDER
GlaxoSmithKline
Operational Intelligence
[ M ]
Legal Name
GlaxoSmithKline
HQ Jurisdiction
United Kingdom
Market Sector
Healthcare
Capital Capacity
$100K
Entity Intelligence Summary
GlaxoSmithKline (GSK) is a global biopharma company that prioritizes innovation in vaccines and specialty medicines to prevent and treat disease. Based in London, the firm operates with a focus on immunology and human genetics to drive R&D. GSK is a significant institutional source of capital for global health initiatives and pharmaceutical expansion.
Capital Deployment Log (Transactions)
| Date | Recipient | Type | Amount |
|---|---|---|---|
| 09/01/2024 | GSK Aiolos Platform | EQUITY | $140,000,000 |
| 28/06/2023 | Bellus Health | EQUITY | $2,000,000,000 |
| 28/06/2023 | Bellus Health | EQUITY | $2,000,000,000 |
| 09/01/2024 | Aiolos Bio | EQUITY | $1,400,000,000 |